Accelerated share repurchase programs are typically viewed positively by the market as they often lead to an immediate EPS boost and reflect the company's confidence in its own financial stability and future prospects. Given the size of the transaction, this is likely to be seen as a strong commitment to returning value to shareholders, potentially leading to a positive short-term impact on Altria's stock price.

The impact on Anheuser-Busch InBev's stock (BUD) is less direct and more dependent on market perception. The sale of BUD stock by Altria could be seen in various lights, potentially as Altria divesting from non-core assets or as a move to focus on its primary operations. Without negative implications directly stated, the impact is considered neutral to slightly positive, assuming the market perceives the sale as a strategic move by Altria without reflecting negatively on BUD's fundamentals.